Reduced miR-26b Expression in Megakaryocytes and Platelets Contributes to Elevated Level of Platelet Activation

Bernadett Szilágyi1,2, Zsolt Fejes1,2, Szilárd Póliska3

  • 1Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

Insights

Sepsis reduces miR-26b levels in platelets and megakaryocytes, increasing platelet activation and thrombosis risk. This decrease in miR-26b is linked to disease severity and mortality in septic patients.

Area of Science:

  • Hematology
  • Molecular Biology
  • Immunology

Background:

  • Sepsis can activate platelets via toll-like receptors (TLRs), leading to microvascular thrombosis.
  • Megakaryocytes (MKs), the precursors of platelets, also express TLRs, suggesting infection may affect thrombopoiesis.

Purpose of the Study:

  • To investigate sepsis-induced microRNA (miRNA) expression changes in platelets.
  • To explore the role of altered miRNA levels, specifically miR-26b, in platelet activation during sepsis.
  • To evaluate the impact of Dicer levels on miRNA expression in sepsis.

Main Methods:

  • miRNA profiling in platelets from septic patients and healthy controls using TaqMan Open Array.
  • Validation of miR-26b and its target SELP (P-selectin) mRNA levels.
  • RNA-sequencing of MEG-01 cells treated with lipopolysaccharide (LPS) to analyze MK transcriptome.
  • Experimental manipulation of Dicer1 and calpain in MEG-01 cells to study miR-26b regulation.

Main Results:

  • 121 miRNAs were significantly decreased and 61 upregulated in septic platelets compared to controls.
  • Septic platelets exhibited reduced miR-26b levels, correlating with disease severity and mortality.
  • Elevated SELP mRNA levels and increased P-selectin expression were observed in septic platelets.
  • Dicer1 downregulation led to decreased miR-26b and increased SELP mRNA, while calpeptin treatment restored miR-26b.

Conclusions:

  • Decreased miR-26b in megakaryocytes and platelets is a key factor in heightened platelet activation during sepsis.
  • Reduced miR-26b contributes to the pro-thrombotic state observed in sepsis.
  • miR-26b may serve as a potential biomarker for sepsis severity and outcomes.